Astrocytes and disease: a neurodevelopmental perspective.
By A. Molofsky, Robert Krencik, E. Ullian, Hui-hsin Tsai, B. Deneen, W. Richardson, B. Barres, D. Rowitch. Genes & Development, 2012
653 citations recorded by the source corpus.
Astrocytes are no longer seen as a homogenous population of cells. In fact, recent studies indicate that astrocytes are morphologically and functionally diverse and play critical roles in neurodevelopmental diseases such as Rett syndrome and fragile X mental retardation. This review summarizes recent advances in astrocyte development, including the role of neural tube patterning in specification and developmental functions of astrocytes during synaptogenesis. We propose here that a precise understanding of astrocyte development is critical to defining heterogeneity and could lead advances in understanding and treating a variety of neuropsychiatric diseases.
Subfields: Developmental Neuroscience, Genetics, Neurology
View Paper: https://www.semanticscholar.org/paper/6bcf00e207a1f2dce81f2f9c46f6e1b578376be2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Developmental Neuroscience
In Neurology
Citations in the corpus
- Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse (2015, neutral): “They obtained transcriptome profiles of purified human CNS cell types and discovered two distinct stages of human astrocyte development.”
- Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. (2013, background): “on the function of astrocytes participating in the composition of blood brain barrier (BBB) (Molofsky et al., 2012) and various”
- An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex (2014, background): “…spectrum disorders, epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and stroke (Matute et al., 2005; Tian et al., 2005; Nagai et al., 2007; Chen et al., 2009; Li et al., 2011; Lioy et al., 2011; Molofsky et al., 2012; Zamanian et al., 2012).”